JGCM
IDXX icon

Joseph Group Capital Management’s Idexx Laboratories IDXX Stock Holding History

Joseph Group Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5K Buy
20
+2
+11% +$1.12K ﹤0.01% 332
2026
Q1 		$10.1K Buy
+18
New +$11.5K ﹤0.01% 273

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Joseph Group Capital Management's IDXX Position: Q2 2026 in Review

Joseph Group Capital Management increased its Idexx Laboratories (IDXX) stake by 11% in Q2 2026, buying an estimated $1.12K and bringing the position to 20 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #332.

Joseph Group Capital Management first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Joseph Group Capital Management held 20 shares of Idexx Laboratories worth $10.5K as of Q2 2026.
  • Joseph Group Capital Management bought 2 Idexx Laboratories shares in Q2 2026, an estimated $1.12K.
  • Idexx Laboratories made up ﹤0.01% of Joseph Group Capital Management's portfolio in Q2 2026, its #332 holding.
  • Joseph Group Capital Management first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Joseph Group Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.